Patients Ending the silence: Why the menopause matters in the workpla... One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.